Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02827838
Title Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Comprehensive Cancer Center of Wake Forest University
Indications

oral squamous cell carcinoma

head and neck squamous cell carcinoma

oropharynx cancer

Therapies

Durvalumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.